Novartis India Files FY26 BRSR Report

Novartis India Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report details the company's initiatives from an Environmental, Social, and Governance (ESG) perspective, aligning with the National Guidelines on Responsible Business Conduct. As a trading entity, Novartis India focuses on pharmaceuticals trading, accounting for 100% of its turnover. The company serves markets nationally, with no export contribution. The BRSR is prepared on a standalone basis and includes disclosures aligned with its promoter, Novartis AG's policies. The report is available on the company's website.